undamentalytics Newsletter
Sign in

Shattuck Labs, Inc. income statement

In fiscal 2025, Shattuck Labs, Inc. reported revenue of $1.0m, down 82.5% on the year before, operating income of −$51.5m (a -5150.8% margin) and net income of −$48.8m, or −$0.70 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue10103012611
Research and development2937578374673539
General and administrative69192119191717
Operating income−25−37−45−103−92−81−52−56
Income tax0000000—
Net income−24−37−45−102−87−75−49−53
Diluted EPS−$1.58−$2.36−$1.07−$2.41−$2.05−$1.49−$0.70—
Diluted shares (average)15m16m42m42m43m51m70m—
EBITDA−25−36−44−100−88−77−48−52

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MNOV vs STTKLGVN vs STTKDARE vs STTK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Shattuck Labs, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Shattuck Labs, Inc.